​

BriaCell Therapeutics (BCTX) Revenue & Revenue Breakdown

OverviewFinancialsChart

BriaCell Therapeutics Revenue Highlights

00

BriaCell Therapeutics Revenue by Period

BriaCell Therapeutics Revenue by Year

DateRevenueChange
2024-07-31-100.00%
2023-07-31-100.00%
2022-07-31-100.00%
2021-07-31-100.00%
2020-07-31-100.00%
2019-07-31-100.00%
2018-07-31-100.00%
2017-07-31-100.00%
2016-07-31-100.00%
2015-07-31-100.00%
2014-07-31-100.00%
2013-07-31-100.00%
2012-07-31-100.00%
2011-07-31-100.00%
2010-07-31-100.00%
2009-07-31-100.00%
2008-07-31-100.00%
2007-07-31-100.00%
2006-07-31--

BriaCell Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

BriaCell Therapeutics Revenue by Quarter

DateRevenueChange
2025-01-31-100.00%
2024-10-31--100.00%
2024-07-31$22.67K100.00%
2024-04-30-100.00%
2024-01-31-100.00%
2023-10-31-100.00%
2023-07-31-100.00%
2023-04-30-100.00%
2023-01-31-100.00%
2022-10-31-100.00%
2022-07-31-100.00%
2022-04-30-100.00%
2022-01-31-100.00%
2021-10-31-100.00%
2021-07-31-100.00%
2021-04-30-100.00%
2021-01-31-100.00%
2020-10-31-100.00%
2020-07-31-100.00%
2020-04-30-100.00%
2020-01-31-100.00%
2019-10-31-100.00%
2019-07-31-100.00%
2019-04-30-100.00%
2019-01-31-100.00%
2018-10-31-100.00%
2018-07-31-100.00%
2018-04-30-100.00%
2018-01-31-100.00%
2017-10-31-100.00%
2017-07-31-100.00%
2017-04-30-100.00%
2017-01-31-100.00%
2016-10-31-100.00%
2016-07-31-100.00%
2016-04-30-100.00%
2016-01-31-100.00%
2015-04-30-100.00%
2015-01-31-100.00%
2014-10-31-100.00%
2014-07-31-100.00%
2014-04-30-100.00%
2014-01-31-100.00%
2013-10-31-100.00%
2013-07-31-100.00%
2013-04-30-100.00%
2013-01-31-100.00%
2012-10-31-100.00%
2012-07-31-100.00%
2012-04-30-100.00%
2012-01-31-100.00%
2011-10-31-100.00%
2011-07-31-100.00%
2011-04-30-100.00%
2011-01-31-100.00%
2010-10-31-100.00%
2010-07-31-100.00%
2010-04-30-100.00%
2010-01-31-100.00%
2009-10-31-100.00%
2009-07-31-100.00%
2009-04-30-100.00%
2009-01-31-100.00%
2008-10-31-100.00%
2008-07-31-100.00%
2008-04-30--

BriaCell Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

BriaCell Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DAWNDay One Biopharmaceuticals$131.16M$20.07M
XFORX4 Pharmaceuticals$2.56M$560.00K
BCTXBriaCell Therapeutics--
PDSBPDS Bio--
HEPAHepion Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
ELEVElevation Oncology--
HOOKHOOKIPA Pharma-$4.70M
MREOMereo BioPharma Group--

BCTX Revenue FAQ

What is BriaCell Therapeutics’s yearly revenue?

BriaCell Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. BCTX's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is BriaCell Therapeutics’s quarterly revenue?

BriaCell Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). BCTX's quarterly revenue for Q4 2024 was $22.67K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023).

What is BriaCell Therapeutics’s revenue growth rate?

BriaCell Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.